Literature DB >> 18484335

Odontogenic ameloblast-associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles.

Charles L Murphy1, Daniel P Kestler, James S Foster, Shuching Wang, Sallie D Macy, Stephen J Kennel, Eric R Carlson, John Hudson, Deborah T Weiss, Alan Solomon.   

Abstract

We have previously reported that the amyloid found in three patients with calcifying epithelial odontogenic tumors (CEOT) was composed of N-terminal fragments of a putative 153-residue protein specified by a gene designated FLJ20513 now known to represent exons 5 through 10 of the odontogenic ameloblast-associated protein (ODAM) locus that encodes a 279-residue polypeptide. Confirmation of the amyloidogenic potential of ODAM has resulted from analyses of four other cases where we found, in addition, a 74-residue segment specified by exon 4. Through preparation of ODAM-related synthetic peptides, it was possible to localize the fibril-forming region of this molecule, as well as generate a monoclonal antibody that reacted specifically with the amyloid associated with CEOT. Notably, we also detected green birefringent congophilic material in unerupted tooth follicles - a precursor of CEOT - and demonstrated through immunologic and chemical analyses the ODAM nature of the deposits. Our studies have provided further evidence for this unique form of odontogenic amyloid that we provisionally designate "AODAM".

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484335     DOI: 10.1080/13506120802005965

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  18 in total

1.  Odontogenic ameloblast-associated and amelotin are novel basal lamina components.

Authors:  Juliana Dos Santos Neves; Rima M Wazen; Shingo Kuroda; Sylvia Francis Zalzal; Pierre Moffatt; Antonio Nanci
Journal:  Histochem Cell Biol       Date:  2012-01-10       Impact factor: 4.304

2.  Odontogenic fibroma, including amyloid and ossifying variants.

Authors:  Lewis R Eversole
Journal:  Head Neck Pathol       Date:  2011-07-13

3.  Establishment and characterization of a primary calcifying epithelial odontogenic tumor cell population.

Authors:  Hope M Amm; Douglas L Rollins; Changchun Ren; Juan Dong; Patricia DeVilliers; Helen Rivera; Mary MacDougall
Journal:  J Oral Pathol Med       Date:  2013-10-11       Impact factor: 4.253

Review 4.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer.

Authors:  Yun Luo; Jie-Ying Wu; Guo-Liang Hou; Min-Hua Lu; Zhi Shi; Jin-Ming Di
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  Controversies in Odontogenic Tumours: Review.

Authors:  Pooja Siwach; Tabita Joy; Jagdish Tupkari; Arush Thakur
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

7.  Targeting the sonic hedgehog pathway in keratocystic odontogenic tumor.

Authors:  Changchun Ren; Hope M Amm; Patricia DeVilliers; Yixin Wu; Joseph R Deatherage; Zhongyu Liu; Mary MacDougall
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

8.  ODAM Expression Inhibits Human Breast Cancer Tumorigenesis.

Authors:  Daniel P Kestler; James S Foster; Charles T Bruker; John W Prenshaw; Stephen J Kennel; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Breast Cancer (Auckl)       Date:  2011-04-28

9.  Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms.

Authors:  Daniel P Kestler; James S Foster; Sallie D Macy; Charles L Murphy; Deborah T Weiss; Alan Solomon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.

Authors:  James S Foster; Lindsay M Fish; Jonathan E Phipps; Charles T Bruker; James M Lewis; John L Bell; Alan Solomon; Daniel P Kestler
Journal:  BMC Cancer       Date:  2013-05-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.